Astera Labs (NASDAQ:ALAB) Reaches New 1-Year High - Here's What Happened

Key Points

• Astera Labs (NASDAQ:ALAB) reached a new 52-week high of $212.65, showing a significant increase in trading volume of over 555,000 shares.
• Analyst ratings reflect a diverse outlook on the stock, with one "Strong Buy", fifteen "Buy", and three "Hold" ratings, and varying price targets ranging from $120.00 to $200.00.
• The company reported a 149.5% increase in revenue for the latest quarter, totaling $191.93 million, and beat earnings expectations with $0.44 EPS compared to the estimate of $0.33.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price reached a new 52-week high on Monday . The stock traded as high as $205.86 and last traded at $212.65, with a volume of 555265 shares changing hands. The stock had previously closed at $191.20.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Northland Securities cut shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target for the company. in a report on Tuesday, July 22nd. Jefferies Financial Group upped their price target on shares of Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Morgan Stanley increased their target price on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a report on Friday, August 29th. Susquehanna increased their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. Finally, Stifel Nicolaus set a $145.00 price target on shares of Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs presently has an average rating of "Moderate Buy" and a consensus target price of $142.00.

Astera Labs Price Performance

The company has a market capitalization of $35.38 billion, a P/E ratio of 376.74, a price-to-earnings-growth ratio of 4.85 and a beta of 1.46. The company's 50-day moving average price is $141.64 and its two-hundred day moving average price is $99.01.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same period last year, the firm earned $0.13 earnings per share. Astera Labs's revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 152,517 shares of the firm's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at approximately $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,832,489 shares of company stock valued at $264,172,396 in the last three months. 12.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

Several hedge funds have recently bought and sold shares of ALAB. Dimensional Fund Advisors LP increased its holdings in Astera Labs by 4.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company's stock valued at $2,417,000 after buying an additional 768 shares during the period. Cetera Investment Advisers bought a new position in Astera Labs in the 4th quarter valued at about $460,000. Cresset Asset Management LLC bought a new position in Astera Labs in the 4th quarter valued at about $216,000. Deutsche Bank AG increased its holdings in Astera Labs by 33.0% in the 4th quarter. Deutsche Bank AG now owns 7,695 shares of the company's stock valued at $1,019,000 after buying an additional 1,909 shares during the period. Finally, Ethic Inc. bought a new position in Astera Labs in the 4th quarter valued at about $656,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.